Voltar
Lucro líquido diluído disponível para acionistas ordinários de GLENMARK PHARMACEUTICALS LTD..
Dados anuais
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
−16,00 B
−8,00 B
0,00
8,00 B
16,00 B
Período
Valor
Variação %
TTM
−1,76 B
+88,29%
2023
−15,02 B
−605,20%
2022
2,97 B
−68,44%
2021
9,42 B
−2,92%
2020
9,70 B
+25,01%
2019
7,76 B
−16,11%
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Dados trimestrais
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−13,50 B
−9,00 B
−4,50 B
0,00
4,50 B
Período
Valor
Variação %
Q3 '24
3,48 B
−1,77%
Q2 '24
3,54 B
+4,10%
Q1 '24
3,40 B
—
Q4 '23
−12,18 B
−246,72%
Q3 '23
−3,51 B
−328,79%
Q2 '23
−819,45 M
−154,65%
Q1 '23
1,50 B
—
Q4 '22
−4,28 B
−257,13%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17
Q1 '17